{"title":"补充维生素促进大肠杆菌治疗性纳米体的产生","authors":"Richa Katiyar , Neha Gindi , Ishika Mittal , Claire Komives , Anurag S. Rathore","doi":"10.1016/j.bej.2025.109887","DOIUrl":null,"url":null,"abstract":"<div><div>As low yields of nanobodies in <em>E.coli.</em> periplasm is a major concern for their large-scale production, this study explores the use of vitamins for enhanced production of a recombinant periplasmic nanobody product. Nanobody producing <em>E.coli</em> cells were cultivated in the modified Terrific-Broth supplemented with three different vitamins (biotin denoted as B, cyanocobalamin as C, and D-calcium pantothenate as P). Multiple combinations (B+P, B+C, P + C, and B+P + C) were examined, with B+P offering the highest specific growth rate, total biomass productivity, product accumulation and product expression. Densitometry analysis revealed 129.17 ± 1.1 mg/L nanobodies in case of B+P supplementation (24 % higher than control). B+P supplementation also offered 21 % better fermentation yield than control (as per RP-HPLC). The yield of purified nanobody product in case of B+P supplementation was at 35.0 ± 2.1 mg/L with purity levels of ≥ 80 %. Intact mass and peptide mapping analysis of purified nanobody revealed molecular weight of 15.2 kDa and 91 % sequence coverage with the theoretical nanobody sequence respectively. Spent media analysis revealed production of low acetate in case of B+P supplementation of media when compared to other conditions examined. Hence, the B+P supplementation could be used to produce improved amount of periplasmic nanobody in future.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"223 ","pages":"Article 109887"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vitamin supplementation for enhanced production of therapeutic nanobody in E.coli\",\"authors\":\"Richa Katiyar , Neha Gindi , Ishika Mittal , Claire Komives , Anurag S. Rathore\",\"doi\":\"10.1016/j.bej.2025.109887\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>As low yields of nanobodies in <em>E.coli.</em> periplasm is a major concern for their large-scale production, this study explores the use of vitamins for enhanced production of a recombinant periplasmic nanobody product. Nanobody producing <em>E.coli</em> cells were cultivated in the modified Terrific-Broth supplemented with three different vitamins (biotin denoted as B, cyanocobalamin as C, and D-calcium pantothenate as P). Multiple combinations (B+P, B+C, P + C, and B+P + C) were examined, with B+P offering the highest specific growth rate, total biomass productivity, product accumulation and product expression. Densitometry analysis revealed 129.17 ± 1.1 mg/L nanobodies in case of B+P supplementation (24 % higher than control). B+P supplementation also offered 21 % better fermentation yield than control (as per RP-HPLC). The yield of purified nanobody product in case of B+P supplementation was at 35.0 ± 2.1 mg/L with purity levels of ≥ 80 %. Intact mass and peptide mapping analysis of purified nanobody revealed molecular weight of 15.2 kDa and 91 % sequence coverage with the theoretical nanobody sequence respectively. Spent media analysis revealed production of low acetate in case of B+P supplementation of media when compared to other conditions examined. Hence, the B+P supplementation could be used to produce improved amount of periplasmic nanobody in future.</div></div>\",\"PeriodicalId\":8766,\"journal\":{\"name\":\"Biochemical Engineering Journal\",\"volume\":\"223 \",\"pages\":\"Article 109887\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-07-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical Engineering Journal\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1369703X2500261X\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X2500261X","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Vitamin supplementation for enhanced production of therapeutic nanobody in E.coli
As low yields of nanobodies in E.coli. periplasm is a major concern for their large-scale production, this study explores the use of vitamins for enhanced production of a recombinant periplasmic nanobody product. Nanobody producing E.coli cells were cultivated in the modified Terrific-Broth supplemented with three different vitamins (biotin denoted as B, cyanocobalamin as C, and D-calcium pantothenate as P). Multiple combinations (B+P, B+C, P + C, and B+P + C) were examined, with B+P offering the highest specific growth rate, total biomass productivity, product accumulation and product expression. Densitometry analysis revealed 129.17 ± 1.1 mg/L nanobodies in case of B+P supplementation (24 % higher than control). B+P supplementation also offered 21 % better fermentation yield than control (as per RP-HPLC). The yield of purified nanobody product in case of B+P supplementation was at 35.0 ± 2.1 mg/L with purity levels of ≥ 80 %. Intact mass and peptide mapping analysis of purified nanobody revealed molecular weight of 15.2 kDa and 91 % sequence coverage with the theoretical nanobody sequence respectively. Spent media analysis revealed production of low acetate in case of B+P supplementation of media when compared to other conditions examined. Hence, the B+P supplementation could be used to produce improved amount of periplasmic nanobody in future.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.